Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens.

Biotechnology

Xenetic Biosciences

Xenetic Biosciences' headquarters in Framingham, MA, United States

Jim Parslow, CPA, MBA

James F. Parslow

Alexey Vinogradov

Allan Tsung

Jonathan Spicer

Adam Logal

Grigory G. Borisenko

James Eric Callaway

Firdaus Jal Dastoor

Roger Kornberg

Matthew Frigault

Guenther Koehne

Maksim Mamonkin

The Scientific Advisors team at Xenetic Biosciences provides expert guidance and insights on the development of the XCART platform, leveraging their extensive knowledge in immunology and cancer biology. They collaborate with research and clinical teams to ensure alignment with scientific innovation, regulatory standards, and patient-specific approaches, ultimately enhancing the efficacy of personalized CAR T therapies.

Scientific Advisors

The Leadership Team at Xenetic Biosciences drives the strategic vision and operational direction of the company, overseeing the development and commercialization of its XCART platform. Comprised of key executives, including the Chief Scientific Officer and Chief Financial Officer, this team collaborates to ensure innovation in personalized CAR T therapies while managing financial sustainability and regulatory compliance.

Leadership Team

Xenetic Biosciences

Org chart

Board & advisors

Teams

Scientific Advisors

Leadership Team

Offices

Xenetic Biosciences

Org chart

Board & advisors

Teams

Scientific Advisors

Leadership Team

Offices

Related companies